Ahrens Investment Partners’s ARK Genomic Revolution ETF ARKG Stock Holding History

Ahrens Investment Partners’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	$12.2K	Buy	+405	New	+$12.5K	0.01%	578
2022 Q3	–	Sell	-645	Closed	-$20K	–	201
2022 Q2	$20K	Sell	645 -425	-40%	-$14.9K	0.01%	497
2022 Q1	$49K	Sell	1,070 -1,065	-50%	-$50.8K	0.02%	394
2021 Q4	$131K	Sell	2,135 -4,633	-68%	-$320K	0.06%	248
2021 Q3	$506K	Sell	6,768 -1,725	-20%	-$145K	0.24%	105
2021 Q2	$786K	Sell	8,493 -18,997	-69%	-$1.62M	0.36%	76
2021 Q1	$2.44M	Sell	27,490 -3,264	-11%	-$324K	1.23%	14
2020 Q4	$2.87M	Buy	30,754 +26,993	+718%	+$2.15M	1.54%	14
2020 Q3	$240K	Buy	+3,761	New	+$220K	0.16%	132

Other funds holding ARKG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Ahrens Investment Partners's ARKG Position: Q1 2023 in Review

Ahrens Investment Partners opened a new position in ARK Genomic Revolution ETF (ARKG) in Q1 2023: 405 shares worth $12.2K. The stake represents 0.01% of the portfolio and ranks #578 among its holdings. This is a return to the name: Ahrens Investment Partners previously reported a position in ARKG as recently as Q2 2022.

Ahrens Investment Partners first reported a position in ARKG in Q3 2020 and has held it in 9 quarters since. The position peaked at $2.87M in Q4 2020. 295 funds tracked by Wall St. Rank hold ARKG as of Q1 2023.

Ahrens Investment Partners held 405 shares of ARK Genomic Revolution ETF worth $12.2K as of Q1 2023.
ARK Genomic Revolution ETF was a new Ahrens Investment Partners position in Q1 2023.
ARK Genomic Revolution ETF made up 0.01% of Ahrens Investment Partners's portfolio in Q1 2023, its #578 holding.
Ahrens Investment Partners first reported a position in ARK Genomic Revolution ETF in Q3 2020 and has held it in 9 quarters since.
Ahrens Investment Partners's ARK Genomic Revolution ETF position peaked at $2.87M in Q4 2020.
295 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2023.

Based on Ahrens Investment Partners's 13F filing for Q1 2023, filed 24 Apr 2023.